These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 12230649)

  • 41. [Stimulant therapy in children].
    Steinhausen HC
    Pharmacopsychiatria; 1982 Nov; 15(6):181-2. PubMed ID: 6130534
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of hyperactivity in children with pervasive developmental disorders.
    Scahill L; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238
    [No Abstract]   [Full Text] [Related]  

  • 43. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M
    Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281
    [No Abstract]   [Full Text] [Related]  

  • 44. The preschool ADHD Treatment Study (PATS) as the culmination of twenty years of clinical trials in pediatric psychopharmacology.
    March JS
    J Am Acad Child Adolesc Psychiatry; 2011 May; 50(5):427-30. PubMed ID: 21515189
    [No Abstract]   [Full Text] [Related]  

  • 45. Clonidine for stimulant-related sleep problems.
    Rubinstein S; Silver LB; Licamele WL
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):281-2. PubMed ID: 8150803
    [No Abstract]   [Full Text] [Related]  

  • 46. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological management of treatment-induced insomnia in ADHD.
    Kratochvil CJ; Lake M; Pliszka SR; Walkup JT
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):499-501. PubMed ID: 15843773
    [No Abstract]   [Full Text] [Related]  

  • 49. Annotation: Principles of treatment for hyperkinetic disorder: practice approaches for the U.K.
    Overmeyer S; Taylor E
    J Child Psychol Psychiatry; 1999 Nov; 40(8):1147-57. PubMed ID: 10604394
    [No Abstract]   [Full Text] [Related]  

  • 50. Drugs and children.
    Pinkham JR
    ASDC J Dent Child; 2002; 69(1):10. PubMed ID: 12119805
    [No Abstract]   [Full Text] [Related]  

  • 51. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attention deficit hyperactivity disorder.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2003 Jun; (9):318-27. PubMed ID: 12967364
    [No Abstract]   [Full Text] [Related]  

  • 53. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
    Taéron C
    Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children.
    August GJ; Realmuto GM
    Minn Med; 2000 Jun; 83(6):45-6. PubMed ID: 10881573
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical practice. Attention deficit-hyperactivity disorder in children and adolescents.
    Feldman HM; Reiff MI
    N Engl J Med; 2014 Feb; 370(9):838-46. PubMed ID: 24571756
    [No Abstract]   [Full Text] [Related]  

  • 56. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract]   [Full Text] [Related]  

  • 57. Dexmethylphenidate (Focalin) for ADHD.
    Med Lett Drugs Ther; 2002 May; 44(1130):45-6. PubMed ID: 12011757
    [No Abstract]   [Full Text] [Related]  

  • 58. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
    Lurie S; O'Quinn A
    J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controversies in ADHD. Fundamental questions being answered slowly, but scientifically.
    Flick GL
    Adv Nurse Pract; 2002 Feb; 10(2):34-6, 39-43. PubMed ID: 12400297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.